Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer.

Yeh Chen LeeLisa WangElise C KohnLawrence RubinsteinS Percy IvyPamela J HarrisStéphanie Lheureux

Published in: Cancer (2020)

Women with gynecologic cancer experienced more frequent low-grade AEs during treatment, and this warrants attention to support their symptom burden. Study dose management should be considered for recurrent grade 2 AEs, particularly during continuous therapy.

Keyphrases

low grade
papillary thyroid
clinical trial
squamous cell
working memory
endometrial cancer
stem cells
childhood cancer
risk factors
young adults
open label
phase iii